TRxADE HEALTH, Inc.

MEDS

US89846A4058

Internet Services

Market Closed - Nasdaq Other stock markets 02:00:00 29/05/2024 am IST			5-day change	1st Jan Change
5.9 ^USD	+4.42%		+0.34%	+13.54%

22/04	TRxADE HEALTH, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
06/03	Top Midday Gainers	MT

Trxade Group, Inc. Appoints Dr. Ramesh Kenchappa as Chief Scientific Officer

September 30, 2014 at 08:17 pm IST

Trxade Group, Inc. announced the launch of new direct sales model through its wholly owned subsidiary, Westminster Pharmaceuticals, LLC. In connection with this new profit center, Dr. Ramesh Kenchappa, M.S.(Pharma), Ph.D., is joining the Company as Chief Scientific Officer.
Dr. Ramesh will manage the Research &Development team at Westminster Pharmaceuticals.

Latest news about TRxADE HEALTH, Inc.

TRxADE HEALTH, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	23/04	CI
Top Midday Gainers	07/03	MT
TRxADE Health Shares Soar After Company Says to Pay Special Dividend	06/03	MT
Trxade Health, Inc. Announces Special Cash Dividend, Payable on or About March 22, 2024	06/03	CI
Superlatus Foods, Inc. acquired Superlatus, Inc from TRxADE HEALTH, Inc. for $1.	06/03	CI
Top Premarket Gainers	20/02	MT
TRxADE HEALTH, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	17/01	CI
TRxADE Health's Superlatus Enters Distribution Deal With Rainforest Distribution	12/23/12	MT
TRxADE HEALTH's Superlatus Acquires Spero Foods Assets	04/23/04	MT
TRxADE HEALTH, Inc. announced that it expects to receive $0.29 million in funding	04/23/04	CI
TRxADE Health Says Superlatus to Acquire Urgent Company; Shares Jump	22/23/22	MT
TRxADE HEALTH, Inc. entered into a binding agreement to acquire The Urgent Company, Inc. from Perfect Day, Inc.	22/23/22	CI
Tranche Update on TRxADE HEALTH, Inc.'s Equity Buyback Plan announced on May 28, 2021.	19/23/19	CI
TRxADE HEALTH, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	19/23/19	CI
TRxADE Health Reports Form 10-Q Filing Extension	14/23/14	MT
TRxADE HEALTH, Inc. Appoints Candice Beaumont as Director	31/23/31	CI
TRxADE HEALTH, Inc. completed the acquisition of Superlatus, Inc.	31/23/31	CI
TRxADE Health Agrees to Buy Superlatus	30/23/30	MT
Sector Update: Health Care Stocks Weaker Late Monday	27/23/27	MT
Sector Update: Health Care	27/23/27	MT
TRxADE Health Issues Correction to Superlatus Merger Details; Shares Soar	26/23/26	MT
Top Premarket Gainers	26/23/26	MT
Eat Well Up 5.5% As Moves To Sell Sapientia For US$10 Million In Nasdaq Merger	24/23/24	MT
TRxADE Health's Shares Rise Following Superlatus Acquisition Plan	23/23/23	MT
TRxADE Health Plans to Acquire Superlatus, Shift Business Focus to Plant-Based Food Processing	23/23/23	MT

Chart TRxADE HEALTH, Inc.

Duration

Period

More charts

Company Profile

TRxADE Health, Inc. provides a technology-enabled health services platform. The Company is focused on digitalizing the retail pharmacy and health services experience by optimizing drug procurement, the prescription journey, access to physicians in the patientâs home and patient engagement in the United States. The Companyâs segments include Trxade, Inc., Integra Pharma Solutions, LLC (IPS) and Superlatus. Trxade, Inc. segment provides a web-based pharmaceutical marketplace platform-business to business (B2B) sales. IPS is a licensed pharmaceutical wholesaler and sells brand, generic and non-drug products to customers. The Superlatus segment holds Sapientiaâs intellectual property for advanced food extrusion technology and The Urgent Company, which is a manufacturer of ice cream that is animal product-free, vegan, lactose-free, and made with plant-B2B sales. Its subsidiaries include Community Specialty Pharmacy, LLC, Alliance Pharma Solutions, LLC, Bonum Health, LLC and others.

Sector

Internet Services

Calendar

22/07/2024 - Q2 2024 Earnings Release (Projected)

More about the company

	1st Jan change	Capi.
TRXADE HEALTH, INC.	+13.54%	82.97L
TENCENT HOLDINGS LIMITED	+26.36%	45TCr
NETFLIX, INC.	+33.30%	28TCr
UBER TECHNOLOGIES, INC.	+3.17%	13TCr
PROSUS N.V.	+25.87%	9.26TCr
AIRBNB, INC.	+7.98%	9.33TCr
SPOTIFY TECHNOLOGY S.A.	+65.13%	6.15TCr
DOORDASH, INC.	+13.70%	4.6TCr
NASPERS LIMITED	+22.96%	3.69TCr
COSTAR GROUP, INC.	-4.73%	3.4TCr

Other Internet Services

TRxADE HEALTH, Inc.

Equities

MEDS

US89846A4058

Internet Services

Trxade Group, Inc. Appoints Dr. Ramesh Kenchappa as Chief Scientific Officer

Latest news about TRxADE HEALTH, Inc.

Chart TRxADE HEALTH, Inc.

Company Profile

Income Statement Evolution

Quarterly earnings - Rate of surprise

Sector Other Internet Services